Showing results (3061-3070 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 24, 2014
Cost effectiveness of liraglutide in type II diabetes: a systematic reviewPatrick M Zueger, Neil M Schultz, Todd A LeePharmacoeconomics|July 17, 2014
Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experimentPeter Ghijben, Emily Lancsar, Silva ZavarsekPharmacoeconomics|January 19, 2013
A systematic and critical review of the evolving methods and applications of value of information in academia and practiceLotte Steuten, Gijs van de Wetering, Karin Groothuis-Oudshoorn, et al.Pharmacoeconomics|May 10, 2013
Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidenceChantal W M van Gils, Saskia de Groot, William K Redekop, et al.Pharmacoeconomics|April 10, 2013
Trabectedin for the treatment of advanced metastatic soft tissue sarcoma: a NICE single technology appraisalRachid Rafia, Emma Simpson, Matt Stevenson, et al.Pharmacoeconomics|April 27, 2013
Productivity costs in economic evaluations: past, present, futureMarieke Krol, Werner Brouwer, Frans RuttenPharmacoeconomics|April 27, 2013
Random regret-based discrete-choice modelling: an application to healthcareEsther W de Bekker-Grob, Caspar G ChorusPharmacoeconomics|April 11, 2013
The determinants of cost-effectiveness potential: an historical perspective on lipid-lowering therapiesRodrigo Refoios Camejo, Clare McGrath, Marisa Miraldo, et al.Pharmacoeconomics|April 12, 2013
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisalJonathan Tosh, Rachel Archer, Sarah Davis, et al.Pharmacoeconomics|February 19, 2013
The economic burden of depression in SwitzerlandYuki Tomonaga, Josef Haettenschwiler, Martin Hatzinger, et al.Pageof 336